Major Market Shift in Oncology Molecular Diagnostics Industry: Revolutionizing Oncology Molecular Diagnostics Through Advanced Genomics Technology

What Is the Forecasted Market Size and Growth Rate for the Oncology Molecular Diagnostics Market?
The market for oncology molecular diagnostics has seen considerable growth in recent years. It is anticipated that it will expand from $4.84 billion in 2024 to $5.65 billion in 2025, with a compound annual growth rate (CAGR) of 16.7%. The growth experienced in the historic period is due to factors such as the introduction of early tests, advancements in genomic profiling, adoption of next-generation sequencing (NGS), identification of early biomarkers, and the evolution of targeted therapies.

The market size of oncology molecular diagnostics is anticipated to witness notable expansion in the coming years. By 2029, it is projected to reach $8.99 billion, with a compound annual growth rate (CAGR) of 12.3%. The expected growth during the forecast period is likely due to the development in liquid biopsy, the emergence of companion diagnostics, the inclusion of AI (Artificial Intelligence), the expansion of NGS (Next Generation Sequencing) applications, and the evolution of biomarker identification. Some significant trends during the forecast period are global availability, the discovery and validation of biomarkers, refinement of regulatory frameworks, improvements in technological platforms and patient orientated care models.

What Factors Are Propelling the Expansion of the Oncology Molecular Diagnostics Market?
The global increase in cancer cases is expected to fuel the expansion of the oncology molecular diagnostics market. The American Cancer Society, for example, reported approximately 1.9 million new cancer diagnoses and 609,360 cancer-associated fatalities in the U.S in 2022. Projections for 2023 were similar, with nearly 1,958,310 new cases of cancer and approximately 609,820 cancer-related deaths. The four most prevalent cancers globally include lung, prostate, bowel, and female breast cancer. Thus, the global surge in cancer occurrence is predicted to propel the demand for the oncology molecular diagnostics market in the forthcoming years.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3457&type=smp

Which Businesses Are at the Forefront of Oncology Molecular Diagnostics Market Development?
Major companies operating in the oncology molecular diagnostics market include F. Hoffmann-La Roche AG, Bayer AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthcare AG, Becton Dickinson and Company, Agilent Technologies Inc., HTG Molecular Diagnostics Inc., Hologic Inc., Illumina Inc., bioMérieux SA, Beckman Coulter Inc., Sysmex Corporation, Bio-Rad Laboratories Inc., Qiagen N.V., Exact Sciences Corp., Bio-Techne Corporation, OPKO Health Inc., Myriad Genetics Inc., Guardant Health AMEA, Veracyte Inc., Adaptive Biotechnologies Corp., Foundation Medicine Inc., Pacific Biosciences of California Inc., NanoString Technologies Inc., Genomic Health Inc.

What Are the Latest Innovations in the Oncology Molecular Diagnostics Market?
The cutting-edge developments in genomics have been identified as a significant trend in the oncology molecular diagnostics market. Enhancement in cancer genome sequencing technology, computational examination, tumor modeling, and the introduction of contemporary cancer research approaches facilitate early detection of cancer and its mutation. For instance, OncoHelix-CoLab, a Canada-based institution specializing in precision oncology with a focus on genomic and immunologic profiling for cancer treatment, advanced molecular diagnostics and immune profile testing laboratory, launched its state-of-the-art facility at Burjeel Medical City in the UAE in May 2024. A result of the collaborative efforts of Burjeel Holdings and OncoHelix, the facility provides a broad spectrum of capabilities in molecular, cellular immunology and transplant diagnostics. The laboratory aims to enhance diagnostic accuracy and efficiency by conducting intricate tests locally, thus eliminating the need to ship samples overseas. The Lab's advanced tests include those for various cancers, such as prostate cancer, which are conducted through collaborations like the one with Nanostics for the ClarityDX Prostate test.

How Is the Oncology Molecular Diagnostics Market Segmented?
The oncology molecular diagnostics market covered in this report is segmented -

1) By Product: Instruments, Reagents, Other Products
2) By Technology: Polymerase Chain Reaction (PCR), In-situ Hybridization (ISH), Isothermic Nucleic Acid Amplification Technology (INNAT), Chips & Microarrays, Sequencing, Mass Spectroscopy, Transcription Mediated Amplification (TMA), Other Technologies
3) By End User: Hospitals, Diagnostic Centers, Academic & Research Institutes, Other End Users

Subsegments:
1) By Instruments: PCR (Polymerase Chain Reaction) Machines, Sequencers, Microarray Platforms, Fluorescence In Situ Hybridization (FISH) Instruments
2) By Reagents: DNA And RNA Extraction Kits, PCR Reagents And Kits, NGS Library Preparation Kits, Diagnostic Assay Reagents
3) By Other Products: Software For Data Analysis And Interpretation, Quality Control And Calibration Products, Consumables, For Molecular Testing, Biomarkers For Oncology Testing

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/oncology-molecular-diagnostics-global-market-report

Where Is the Oncology Molecular Diagnostics Market Growth Most Prominent?
The countries covered in the oncology molecular diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Is Covered In The Oncology Molecular Diagnostics Global Market Report?

- Market Size Analysis: Analyze the Oncology Molecular Diagnostics Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Oncology Molecular Diagnostics Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Oncology Molecular Diagnostics Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Oncology Molecular Diagnostics Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3457

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.